MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202521015290 A) filed by Rungta International Skills University; Rungta College Of Engineering & Technology; and Rungta College Of Pharmaceutical Sciences And Research on February 22, 2025, for An Intelligent Transdermal Patch Device For Neurogenic Pain Management And Feedback.
Inventors include Deepika Sahu; Akansha Thakur; Dr. Sanjay Kumar Gupta; Dr. Debarshi Kar Mahapatra; Astha Verma; Dron Kumar Sahu; Suchita Wamankar; Shweta Dutta; and Parveen Nehra.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: An Intelligent Transdermal Patch Device for Neurogenic Pain Management and Feedback This invention describes an intelligent transdermal patch device for neurogenic pain management, combining advanced drug delivery technologies with real-time monitoring and dynamic feedback. The device features a gradient- controlled polymeric drug matrix for dual-phase release, providing immediate and sustained therapeutic effects. An integrated electrochemical iontophoresis module enhances drug permeation into deeper tissues, while an embedded biosensor array continuously monitors physiological parameters, including skin temperature, sweat composition, and nerve conduction. An AI-driven control unit analyzes real-time data to dynamically modulate drug delivery, ensuring personalized and adaptive therapy. The device includes a reusable patch base with replaceable drug layers, promoting cost-efficiency and environmental sustainability. A temperature-regulated surface ensures user comfort, and a wireless communication module connects the patch to a companion mobile application for pain tracking, therapy visualization, and remote healthcare monitoring. This device offers a tailored, efficient, and sustainable solution for managing chronic neurogenic pain.
Disclaimer: Curated by HT Syndication.
